 Kymera is one of several biotechs pioneering targeted protein degradation science and technology - removing unwanted proteins by marking them for destruction by the proteasome. The company IPOd in August 2020, and shares have risen from 20, to 79.6 at the time of writing as enthusiasm for the sector rises. 